Effects of contrast media on renal function in patients with cirrhosis: A prospective study
Open Access
- 30 August 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 40 (3) , 646-651
Abstract
Patients with cirrhosis are frequently submitted to radiological procedures that require the administration of contrast media. Contrast media is a well-known cause of renal failure, particularly in the presence of some predisposing conditions. However, it is not known whether cirrhosis constitutes a risk factor for contrast media-induced renal failure. The aim of this study was to assess the possible nephrotoxicity of contrast media in patients with cirrhosis. In a first protocol, renal function was evaluated with sensitive methods (glomerular filtration rate using iothalamate I 125 clearance and renal plasma flow using iodohippurate I 131 clearance) before and 48 hours after the administration of contrast media in 31 patients with cirrhosis (20 with ascites, 5 with renal failure). Solute-free water clearance, urine sodium, prostaglandins, and markers of tubular damage were also measured. The administration of contrast media was not associated with significant changes in renal function tests, neither in the whole group of patients nor in patients with ascites or renal failure. Urinary prostaglandin E2 and N-acetyl-β-d-glucosaminidase increased significantly, but sodium and solute-free water excretion remained unchanged. In a second protocol, a different series of 60 patients with cirrhosis and renal failure were examined prospectively. No patient had renal failure due to contrast media. Only in 1 patient with septic shock was contrast media a possible contributing factor. In conclusion, the administration of contrast media is not associated with adverse effects on renal function in patients with cirrhosis. Cirrhosis does not appear to be a risk factor for the development of contrast media-induced nephrotoxicity. (Hepatology 2004;40:646-651.)Keywords
Funding Information
- Fondo de Investigación Sanitaria (FIS 020701, FIS 013045)
- Instituto de Salud Carlos III (C03/2)
This publication has 24 references indexed in Scilit:
- Hepatorenal syndromeThe Lancet, 2003
- Acute renal failure in patients with cirrhosis: Perspectives in the age of MELDHepatology, 2003
- Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosisHepatology, 2002
- Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosisHepatology, 2001
- Contrast-media-induced nephrotoxicity: a consensus reportEuropean Radiology, 1999
- Prevention of Nephrotoxicity Induced by Radiocontrast AgentsNew England Journal of Medicine, 1994
- Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosisGastroenterology, 1988
- Value of enzyme determinations in urine for the diagnosis of nephrotoxicity in ratsClinica Chimica Acta, 1986
- Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesisThe American Journal of Medicine, 1986
- Effects of sulindac and ibuprofen in patients with cirrhosis and ascitesGastroenterology, 1986